GM22562
LCL from B-Lymphocyte
Description:
EHLERS-DANLOS SYNDROME: TYPE IV; ARTERIAL, ECCHYMOTIC TYPE
COLLAGEN, TYPE III, ALPHA-1; COL3A1
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Family Member
|
2
|
Family History
|
N
|
Relation to Proband
|
cousin
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
COL3A1 |
Chromosomal Location |
2q31 |
Allelic Variant 1 |
G334R; EHLERS-DANLOS SYNDROME, TYPE IV |
Identified Mutation |
GLY334ARG |
Remarks |
Clinically affected; abnormal procollagen III motility by protein electrophoresis; darkening on cheeks; dysplastic auricles; gingivitis; mild micrognathia; mildly high palate; tinged blue sclerae; soft skin; abnormal scarring on lip; piezogenic papules; S-shaped scoliosis; limitation in both shoulders; hyperextension in hips and left knee; pes planus; Beighton score 1/9; chest discomfort for last 5 years; heartburn; slightly tortuous splenic artery; stenosis at origin of celiac artery; mild disc desiccation at L5-S1; moderate stenosis in right common carotid just before entering the petrou portion; minimal disc disease at C3-C4; small multi-level Schmorl's node in mid and lower thoracic; see GM22563 Fibroblast; donor subject is heterozygous for a missense mutation in exon 22 of the COL3A1 gene resulting in the substitution of arginine for glycine at codon 334 [Gly334Arg (G334R)] |
Gene Cards |
COL3A1 |
Gene Ontology |
GO:0005201 extracellular matrix structural constituent |
|
GO:0005581 collagen |
|
GO:0005586 collagen type III |
|
GO:0005737 cytoplasm |
|
GO:0006817 phosphate transport |
|
GO:0008015 circulation |
|
GO:0009887 organogenesis |
NCBI Gene |
Gene ID:1281 |
NCBI GTR |
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1 |
|
130050 EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC |
OMIM |
120180 COLLAGEN, TYPE III, ALPHA-1; COL3A1 |
|
130050 EHLERS-DANLOS SYNDROME, VASCULAR TYPE; EDSVASC |
Omim Description |
EDS IV |
|
EDS4 |
|
EHLERS-DANLOS SYNDROME, ARTERIAL TYPE |
|
EHLERS-DANLOS SYNDROME, ECCHYMOTIC TYPE |
|
EHLERS-DANLOS SYNDROME, SACK-BARABAS TYPE |
|
EHLERS-DANLOS SYNDROME, TYPE IV, AUTOSOMAL DOMINANT |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|